Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Ruxolitinib cream may help treat severe hair loss in children.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Tislelizumab can cause cutaneous lupus erythematosus.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tofacitinib may help treat hair loss in children with alopecia areata.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Erlotinib can cause excessive eyelash growth.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.